封面
市场调查报告书
商品编码
1553439

单光子发射断层扫描市场规模、份额、趋势分析报告:按产品、应用、最终用途、地区和细分市场预测,2024-2030 年

Single-photon Emission Computed Tomography Market Size, Share & Trends Analysis Report By Product (Stand-alone SPECT Systems, Hybrid SPECT Systems), By Application (Cardiology, Oncology), By End Use, By Region, And Segment Forecasts, 2024 - 2030

出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10个工作天内

价格

单光子发射断层扫描市场成长与趋势:

Grand View Research, Inc.最新报告显示,预计2030年全球单光子发射断层扫描市场规模将达45.4亿美元,2024年至2030年复合年增长率为2.78%。

市场由几个关键因素驱动。主要市场驱动因素之一是癌症盛行率的增加。癌症、心血管疾病和神经系统疾病等慢性疾病盛行率的增加是单光子发射电脑断层扫描(SPECT) 市场的关键驱动因素。

随着人口老化,这些疾病的盛行率增加,增加了对 SPECT 影像等准确诊断工具的需求。这一趋势需要引入先进的影像技术,这些技术可以提供有关疾病进展和治疗效果的详细见解,从而推动该地区的 SPECT 市场。

政府透过资助医疗设施和改善先进成像技术的倡议来提供支持,进一步推动了市场成长。此外,SPECT 与 CT (SPECT/CT) 等其他影像方式的整合提高了诊断准确性并扩展了其在各个医学领域的应用。製造商和医疗保健提供者正在积极合作,以推进 SPECT 技术并扩大其临床应用。

Cardinal Health、GE Healthcare 和Siemens Healthineers 等市场主要企业正在投资研发以创新和优化 SPECT 系统。这些公司还与医院和研究机构建立合作伙伴关係,以促进临床试验和 SPECT 成像所需的新型放射性药物的推出。製造商和医疗机构之间的合作使临床医生更容易获得最新技术并改善患者的治疗效果。

新产品的推出和最尖端科技的整合是 SPECT 市场的主要趋势。最近的发展包括开发高解析度成像系统和新型放射性药物,以提高 SPECT 扫描的灵敏度和特异性。例如,引进最先进的扫描仪预计将改变 QEII 健康科学中心的核子医学服务,为临床医生提供更好的诊断和治疗计划的增强工具。这符合该中心透过实施创新技术提供优质医疗保健的承诺。安装此类扫描仪是对医疗基础设施的一项重要投资,旨在改善患者的治疗结果。

此外,将 SPECT/CT 等混合成像系统引入医院环境,将提供准确诊断和治疗计划所需的全面解剖和功能成像,从而彻底改变该领域。例如,2024年5月,Mercy Sullivan医院安装了高科技SPECT/CT影像系统,以增强其诊断能力。此新系统整合了先进的SPECT和CT技术,旨在为各种医疗状况提供详细且准确的影像诊断。

该装置对医院来说是一次重大升级,提高了其更有效地诊断和监测疾病的能力。新的 SPECT/CT 系统旨在透过提供更高解析度的影像和更准确的诊断资讯来支援更好的患者照护。这些创新不仅提高了诊断能力,还促进了医疗保健专业人员之间的跨学科合作,从而製定更有效的患者管理策略。

该市场的主要参与者包括 GE Healthcare、Siemens Healthcare、Koninklijke Philips NV、Spectrum Dynamics Medical、Digirad Corporation、MILabs BV、Mediso Medical Imaging Systems 和 MiE GmbH。主要企业正在采取产品发布等策略措施来服务全球客户。 2022 年 10 月, 频谱 Dynamics 推出 VERITON-CT-400 系列数位 SPECT/CT 扫描仪,宣布数位核医学影像领域取得进展。这些新型扫描仪采用固体检测器技术并具有宽口径配置,使它们能够以更高的精度和能力对高能量同位素进行成像。

单光子发射断层扫描市场报告亮点:

  • 从产品来看,混合SPECT系统占最大的销售份额,2023年将达到67.12%。这些混合系统将 SPECT 的功能性影像功能与 CT 或 MRI 提供的解剖细节整合在一起,提供全面的视图,提高诊断准确性和治疗计划。混合SPECT 系统用于各种医疗应用,包括肿瘤学、循环系统和神经学,可提供对身体生理和解剖学方面的详细了解。
  • 从应用来看,肿瘤学占据市场主导地位,2023年占最大份额,达49.58%。全球癌症发生率上升正在推动核医学影像市场的成长,尤其是 PET 和 SPECT 技术。这些先进的方法因其无与伦比的可视化癌症分子特征的能力而被广泛采用,使人们对这种疾病有了更深入的了解。
  • 以最终用途计算,到 2023 年,医院产业将占据最大的市场占有率,达到 46.9%。这是由于医院先进的成像技术能够及早发现癌症和心血管疾病,从而实现快速介入和治疗。此外,医院和其他公司之间为满足临床需求而建立的联盟和合作关係也有助于市场成长。
  • 由于成熟的医疗保健产业、对创新的承诺、先进的基础设施、对研发的重视、癌症和慢性病的高盛行率以及创新技术的快速采用等因素,北美在全球市场占据主导地位。
  • 预计 2024 年至 2030 年期间,亚太地区将以 3.51% 的复合年增长率成长最快。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章 单光子发射断层扫描 (SPECT) 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 单光子发射断层扫描 (SPECT) 市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第 4 章 单光子发射断层扫描 (SPECT) 市场:按产品分类的估计和趋势分析

  • 细分仪表板
  • 全球单光子发射断层扫描市场:产品变化分析
  • 2018-2030年全球单光子发射断层扫描市场规模及趋势分析
  • 独立 SPECT 系统
  • 混合SPECT系统

第五章单光子发射断层扫描 (SPECT) 市场:按应用估算和趋势分析

  • 细分仪表板
  • 全球单光子发射断层扫描市场:应用变化分析
  • 2018-2030年全球单光子发射断层扫描市场规模及趋势分析
  • 2018-2030年市场规模、预测及趋势分析
  • 心臟病学
    • 2018-2030年市场估计与预测
  • 肿瘤学
    • 2018-2030年市场估计与预测
  • 神经病学
    • 2018-2030年市场估计与预测
  • 其他应用
    • 2018-2030年市场估计与预测

第 6 章 单光子发射断层扫描 (SPECT) 市场:最终用途的估计和趋势分析

  • 细分仪表板
  • 全球单光子发射断层扫描市场:最终用途变化分析
  • 2018-2030年全球单光子发射断层扫描市场规模及趋势分析
  • 医院
  • 影像诊断中心
  • 其他的

第 7 章 单光子发射断层扫描 (SPECT) 市场:按产品、应用和最终用途进行的区域估计和趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概述
  • 2018-2030年市场规模、预测趋势分析:
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 2023年主要企业市场占有率分析
  • 公司定位分析
  • 公司分类(新兴企业、创新企业、领导者)
  • 公司简介
    • GE Healthcare
    • Siemens Healthineers
    • Koninklijke Philips NV
    • Spectrum Dynamics Medical
    • Digirad Corporation
    • MILabs BV
    • Mediso Medical Imaging Systems
    • MiE GmbH
Product Code: GVR-4-68040-411-5

Single-photon Emission Computed Tomography Market Growth & Trends:

The global single-photon emission computed tomography market size is expected to reach USD 4.54 billion by 2030, registering a CAGR of 2.78% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by several key factors. One of the primary market drivers is the increasing prevalence of cancer. The increasing prevalence of chronic disorders such as cancer, cardiovascular diseases, and neurological conditions is a significant driver of the single-photon emission computed tomography (SPECT) market.

As the population ages, the incidence of these diseases rises, creating a greater demand for accurate diagnostic tools such as SPECT imaging. This trend necessitates the adoption of advanced imaging technologies that can provide detailed insights into disease progression and treatment efficacy, thereby boosting the SPECT market in the region.

Government support through funding for healthcare facilities and initiatives to improve access to advanced imaging technologies is further propelling market growth. In addition, the integration of SPECT with other imaging modalities, such as CT (SPECT/CT), enhances diagnostic accuracy and expands its applications in various medical fields.Manufacturers and healthcare providers are actively collaborating to advance SPECT technology and expand its use in clinical practice.

Major players in the market, such as Cardinal Health, GE Healthcare, and Siemens Healthineers, are investing in research and development to innovate and optimize SPECT systems. These companies are also forming partnerships with hospitals and research institutions to facilitate clinical trials and the introduction of new radiopharmaceuticals, which are essential for SPECT imaging. The collaboration between manufacturers and healthcare facilities ensures that the latest technologies are readily available to clinicians, thereby improving patient outcomes.

The launch of new products and the integration of cutting-edge technologies are key trends in the SPECT market. Recent advancements include the development of high-resolution imaging systems and novel radiopharmaceuticals that enhance the sensitivity and specificity of SPECT scans. For instance, the introduction of a cutting-edge scanner is expected to transform nuclear medicine services at QEII Health Sciences Centre by providing clinicians with enhanced tools for better diagnosis and treatment planning. This aligns with the center's commitment to delivering high-quality healthcare through the adoption of innovative technologies. Such scanner's installation represents a significant investment in healthcare infrastructure, aimed at improving patient outcomes.

Further, the introduction of hybrid imaging systems such as SPECT/CT in hospital settings has revolutionized the field by providing comprehensive anatomical and functional imaging, which is crucial for accurate diagnosis and treatment planning. For instance, in May 2024, Mercy Sullivan Hospital installed a high-tech SPECT/CT imaging system, enhancing its diagnostic capabilities. The new system, which integrates advanced SPECT and CT technologies, was designed to provide detailed and accurate imaging for a variety of medical conditions.

The installation marked a significant upgrade for the hospital, improving its ability to diagnose and monitor diseases more effectively. The new SPECT/CT system aims to support better patient care by offering higher resolution images and more precise diagnostic information.These innovations not only improve diagnostic capabilities but also foster greater interdisciplinary collaboration among healthcare professionals, leading to more effective patient management strategies.

Some of the key players in the market are GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Spectrum Dynamics Medical, Digirad Corporation, MILabs B.V., Mediso Medical Imaging Systems, MiE GmbH. Key player are involved in undertaking strategic initiatives such as product launch to cater global clientele. In October 2022, Spectrum Dynamics announced its advancement in digital nuclear medicine imaging with the launch of the VERITON-CT-400 Series Digital SPECT/CT scanners. These new scanners utilize solid-state detector technology and feature a wide-bore configuration, enabling them to image high-energy isotopes with enhanced precision and capability.

Single-photon Emission Computed Tomography Market Report Highlights:

  • Based on product, hybrid SPECT systems accounted for largest revenue share of 67.12% in 2023. These hybrid systems integrate SPECT's functional imaging capabilities with the anatomical detail provided by CT or MRI, offering a comprehensive view that enhances diagnostic accuracy and treatment planning. Hybrid SPECT systems are used in various medical applications, including oncology, cardiology, and neurology, to provide detailed insights into the physiological and anatomical aspects of the body
  • Based on application, oncology dominated the market and accounted for the largest share of 49.58% in 2023. The rising global incidence of cancer is driving the growth of the nuclear imaging market, particularly in PET and SPECT technologies. These advanced modalities have gained widespread adoption due to their unparalleled ability to visualize the molecular characteristics of cancer, providing a deeper understanding of the disease
  • Based on end use, hospitals segment is dominated the end use segments with the largest market share of 46.9% in 2023. This is attributable to advanced imaging technologies in hospitals that enable the early detection of cancer, CVD's, allowing for prompt intervention and treatment. In addition, partnerships & collaborations between hospitals and other companies to meet clinical needs contribute to market growth
  • North America dominated the global market due to the attributed to the well-established healthcare sector, commitment to innovation, advanced infrastructure, a strong emphasis on R&D, the high prevalence of cancer and chronic diseases, and rapid adoption of innovative technologies
  • Asia Pacific region is expected to witness fastest growth with a CAGR of 3.51% over the forecast period from 2024 to 2030, due to presence of manufacturers with innovative devices manufacturing capabilities coupled with accelerated diagnostic research capabilities

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Single-Photon Emission Computed Tomography (SPECT) Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of cancer
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Increasing awareness of diagnostic needs
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. lack of skilled professionals
  • 3.3. Single-Photon Emission Computed Tomography (SPECT) Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Single-Photon Emission Computed Tomography (SPECT) Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Single-Photon Emission Computed Tomography (SPECT) Product Market Movement Analysis
  • 4.3. Global Single-Photon Emission Computed Tomography (SPECT) Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Stand-alone SPECT Systems
    • 4.4.1. Stand-alone SPECT systems market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Hybrid SPECT Systems
    • 4.5.1. Hybrid SPECT systems market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Single-Photon Emission Computed Tomography (SPECT) Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Single-Photon Emission Computed Tomography (SPECT) Application Market Movement Analysis
  • 5.3. Global Single-Photon Emission Computed Tomography (SPECT) Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Cardiology
    • 5.5.1. Cardiology market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Oncology
    • 5.6.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Neurology
    • 5.7.1. Neurology market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Other Application
    • 5.8.1. Other application market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Single-Photon Emission Computed Tomography (SPECT) Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Single-Photon Emission Computed Tomography (SPECT) End Use Market Movement Analysis
  • 6.3. Global Single-Photon Emission Computed Tomography (SPECT) Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Diagnostic Imaging Centers
    • 6.5.1. Diagnostic imaging centers market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Single-Photon Emission Computed Tomography (SPECT) Market: Regional Estimates & Trend Analysis By Product, Application, End Use

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Competitive scenario
      • 7.5.1.3. Regulatory framework/ reimbursement structure
      • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework/ reimbursement structure
      • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework/ reimbursement structure
      • 7.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. Regulatory framework/ reimbursement structure
    • 7.6.2. UK
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework/ reimbursement structure
      • 7.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. Germany
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework/ reimbursement structure
      • 7.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. France
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory framework/ reimbursement structure
      • 7.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Italy
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Regulatory framework/ reimbursement structure
      • 7.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Spain
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Regulatory framework/ reimbursement structure
      • 7.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Norway
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Regulatory framework/ reimbursement structure
      • 7.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Sweden
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Competitive scenario
      • 7.6.8.3. Regulatory framework/ reimbursement structure
      • 7.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.9. Denmark
      • 7.6.9.1. Key country dynamics
      • 7.6.9.2. Competitive scenario
      • 7.6.9.3. Regulatory framework/ reimbursement structure
      • 7.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Regulatory framework/ reimbursement structure
    • 7.7.2. Japan
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework/ reimbursement structure
      • 7.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. China
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework/ reimbursement structure
      • 7.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. India
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Regulatory framework/ reimbursement structure
      • 7.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. Australia
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. Regulatory framework/ reimbursement structure
      • 7.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. South Korea
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Competitive scenario
      • 7.7.6.3. Regulatory framework/ reimbursement structure
      • 7.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.7. Thailand
      • 7.7.7.1. Key country dynamics
      • 7.7.7.2. Competitive scenario
      • 7.7.7.3. Regulatory framework/ reimbursement structure
      • 7.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Regulatory framework/ reimbursement structure
    • 7.8.2. Brazil
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework/ reimbursement structure
      • 7.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. Regulatory framework/ reimbursement structure
      • 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. Regulatory framework/ reimbursement structure
    • 7.9.2. South Africa
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Competitive scenario
      • 7.9.2.3. Regulatory framework/ reimbursement structure
      • 7.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. Saudi Arabia
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Competitive scenario
      • 7.9.3.3. Regulatory framework/ reimbursement structure
      • 7.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. UAE
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Competitive scenario
      • 7.9.4.3. Regulatory framework/ reimbursement structure
      • 7.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.5. Kuwait
      • 7.9.5.1. Key country dynamics
      • 7.9.5.2. Competitive scenario
      • 7.9.5.3. Regulatory framework/ reimbursement structure
      • 7.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Key company market share analysis, 2023
  • 8.4. Company Position Analysis
  • 8.5. Company Categorization (Emerging Players, Innovators and Leaders
  • 8.6. Company Profiles
    • 8.6.1. GE Healthcare
      • 8.6.1.1. Company overview
      • 8.6.1.2. Financial performance
      • 8.6.1.3. Application benchmarking
      • 8.6.1.4. Strategic initiatives
    • 8.6.2. Siemens Healthineers
      • 8.6.2.1. Company overview
      • 8.6.2.2. Financial performance
      • 8.6.2.3. Application benchmarking
      • 8.6.2.4. Strategic initiatives
    • 8.6.3. Koninklijke Philips N.V.
      • 8.6.3.1. Company overview
      • 8.6.3.2. Financial performance
      • 8.6.3.3. Application benchmarking
      • 8.6.3.4. Strategic initiatives
    • 8.6.4. Spectrum Dynamics Medical
      • 8.6.4.1. Company overview
      • 8.6.4.2. Financial performance
      • 8.6.4.3. Application benchmarking
      • 8.6.4.4. Strategic initiatives
    • 8.6.5. Digirad Corporation
      • 8.6.5.1. Company overview
      • 8.6.5.2. Financial performance
      • 8.6.5.3. Application benchmarking
      • 8.6.5.4. Strategic initiatives
    • 8.6.6. MILabs B.V.
      • 8.6.6.1. Company overview
      • 8.6.6.2. Financial performance
      • 8.6.6.3. Application benchmarking
      • 8.6.6.4. Strategic initiatives
    • 8.6.7. Mediso Medical Imaging Systems
      • 8.6.7.1. Company overview
      • 8.6.7.2. Financial performance
      • 8.6.7.3. Application benchmarking
      • 8.6.7.4. Strategic initiatives
    • 8.6.8. MiE GmbH
      • 8.6.8.1. Company overview
      • 8.6.8.2. Financial performance
      • 8.6.8.3. Application benchmarking
      • 8.6.8.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 4 Global single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 5 Global single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 6 North America single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 7 North America single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 8 North America single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 9 North America single-photon emission computed tomography (SPECT) market by Country, 2018 - 2030 (USD Million)
  • Table 10 U.S. single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 11 U.S. single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 12 U.S. single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 13 Canada single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 14 Canada single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 15 Canada single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 16 Mexico single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 17 Mexico single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 18 Mexico single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 19 Europe single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 20 Europe single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 21 Europe single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 22 Europe single-photon emission computed tomography (SPECT) market by Country, 2018 - 2030 (USD Million)
  • Table 23 UK single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 24 UK single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 25 UK single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 26 Germany single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 27 Germany single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 28 Germany single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 29 France single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 30 France single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 31 France single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 32 Italy single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 33 Italy single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 34 Italy single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 35 Spain single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 36 Spain single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 37 Spain single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 38 Denmark single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 39 Denmark single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 40 Denmark single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 41 Sweden single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 42 Sweden single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 43 Sweden single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 44 Norway single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 45 Norway single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 46 Norway single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific single-photon emission computed tomography (SPECT) market by Country, 2018 - 2030 (USD Million)
  • Table 51 China single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 52 China single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 53 China single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 54 Japan single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 55 Japan single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 56 Japan single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 57 India single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 58 India single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 59 India single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 60 Australia single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 61 Australia single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 62 Australia single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 63 Thailand single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 64 Thailand single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 65 Thailand single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 66 South Korea single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 67 South Korea single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 68 South Korea single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 69 Latin America single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 70 Latin America single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 71 Latin America single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 72 Latin America single-photon emission computed tomography (SPECT) market by Country, 2018 - 2030 (USD Million)
  • Table 73 Brazil single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 74 Brazil single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 75 Brazil single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 76 Argentina single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 77 Argentina single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 78 Argentina single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa single-photon emission computed tomography (SPECT) market by Country, 2018 - 2030 (USD Million)
  • Table 83 South Africa single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 84 South Africa single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 85 South Africa single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 89 UAE single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 90 UAE single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 91 UAE single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 93 Kuwait single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 94 Kuwait single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market summary, 2023 (USD Million)
  • Fig. 9 Market segmentation & scope
  • Fig. 10 Market driver impact
  • Fig. 11 Market restraint impact
  • Fig. 12 Porter's analysis
  • Fig. 13 SWOT analysis
  • Fig. 14 Single-photon emission computed tomography (SPECT) market: Product outlook and key takeaways
  • Fig. 15 Single-photon emission computed tomography (SPECT) market: Product movement analysis
  • Fig. 16 Stand-alone SPECT Systems market, 2018 - 2030 (USD Million)
  • Fig. 17 Hybrid SPECT Systems market, 2018 - 2030 (USD Million)
  • Fig. 18 Single-photon emission computed tomography (SPECT) market: Application outlook and key takeaways
  • Fig. 19 Single-photon emission computed tomography (SPECT) market: Application movement analysis
  • Fig. 20 Cardiology market, 2018 - 2030 (USD Million)
  • Fig. 21 Oncology market, 2018 - 2030 (USD Million)
  • Fig. 22 Neurology market, 2018 - 2030 (USD Million)
  • Fig. 23 Other Application market, 2018 - 2030 (USD Million)
  • Fig. 24 Single-photon emission computed tomography (SPECT) market: End Use outlook and key takeaways
  • Fig. 25 Single-photon emission computed tomography (SPECT) market: End Use movement analysis
  • Fig. 26 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 27 Diagnostics imaging centers market, 2018 - 2030 (USD Million)
  • Fig. 28 Research & Development Institutes market, 2018 - 2030 (USD Million)
  • Fig. 29 Neurology imaging centers market, 2018 - 2030 (USD Million)
  • Fig. 30 Other end users market, 2018 - 2030 (USD Million)
  • Fig. 31 Single-photon emission computed tomography (SPECT) market: Regional movement analysis
  • Fig. 32 Single-photon emission computed tomography (SPECT) market: Regional outlook and key takeaways
  • Fig. 33 North America, by country
  • Fig. 34 North America
  • Fig. 35 North America market estimates and forecasts, 2018 - 2030
  • Fig. 36 U.S.
  • Fig. 37 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 38 Canada
  • Fig. 39 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 40 Mexico
  • Fig. 41 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 42 Europe
  • Fig. 43 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 44 UK
  • Fig. 45 UK market estimates and forecasts, 2018 - 2030
  • Fig. 46 Germany
  • Fig. 47 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 48 France
  • Fig. 49 France market estimates and forecasts, 2018 - 2030
  • Fig. 50 Italy
  • Fig. 51 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 52 Spain
  • Fig. 53 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 54 Denmark
  • Fig. 55 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 56 Sweden
  • Fig. 57 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 58 Norway
  • Fig. 59 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 60 Asia Pacific
  • Fig. 61 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 62 China
  • Fig. 63 China market estimates and forecasts, 2018 - 2030
  • Fig. 64 Japan
  • Fig. 65 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 66 India
  • Fig. 67 India market estimates and forecasts, 2018 - 2030
  • Fig. 68 Thailand
  • Fig. 69 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 70 South Korea
  • Fig. 71 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 72 Australia
  • Fig. 73 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 74 Latin America
  • Fig. 75 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 76 Brazil
  • Fig. 77 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 78 Argentina
  • Fig. 79 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 80 Middle East and Africa
  • Fig. 81 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 82 South Africa
  • Fig. 83 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 84 Saudi Arabia
  • Fig. 85 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 86 UAE
  • Fig. 87 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 88 Kuwait
  • Fig. 89 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 90 Heat map analysis
  • Fig. 91 Market participant categorization
  • Fig. 92 Single-photon emission computed tomography (SPECT) market share analysis, 2022
  • Fig. 93 Strategy framework